Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 17;15(16):2157-2163.
doi: 10.1080/15384101.2016.1195532. Epub 2016 Jun 29.

TCGA: Increased oncoprotein coding region mutations correlate with a greater expression of apoptosis-effector genes and a positive outcome for stomach adenocarcinoma

Affiliations

TCGA: Increased oncoprotein coding region mutations correlate with a greater expression of apoptosis-effector genes and a positive outcome for stomach adenocarcinoma

John M Yavorski et al. Cell Cycle. .

Abstract

Oncogene mutations are primarily thought to facilitate uncontrolled cell growth. However, overexpression of oncoproteins likely leads to apoptosis in a feed forward mechanism, whereby a certain level of oncoprotein leads to the activation of pro-proliferation effector genes and higher levels lead to activation of pro-apoptotic effector genes. TCGA STAD barcodes having no oncoprotein coding region mutations represented reduced expression of the apoptosis-effector genes compared with barcodes with multiple oncoprotein coding region mutations. Furthermore, STAD barcodes in a "no-subsequent tumor" group, representing 224 samples, and in a "positive outcome" group, had more oncoprotein coding regions mutated, on average, than barcodes of the new tumor and negative outcome groups, respectively. BRAF, CTNNB1, KRAS and MTOR coding region mutations (as a group) had the strongest association with the no-subsequent tumor group. Tumor suppressor coding region mutations were also correlated with no-subsequent tumor. These results are consistent with an oncoprotein-mediated, feed-forward mechanism of apoptosis in patients. Importantly, the no-subsequent tumor group also had more overall mutations. This result leads to considerations of unhealthy cells or cells with more neo-antigens for immune rejection. However, a probabilistic aspect of mutagenesis is also consistent with more oncoprotein and tumor suppressor protein mutations, in cases of more overall mutations, and thus a higher likelihood of activation of feed forward apoptosis pathways.

Keywords: apoptosis-effector genes; feed-forward apoptosis; oncoprotein mediated apoptosis; stomach adenocarcinoma; tumor suppressor proteins.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Average number of oncoproteins mutated for New Tumor vs. No-subsequent tumor (STAD p < 0.004, BLCA not significant) (detailed in SOM file labeled, “SOM Figures 1, 2 and 3, source file”). The new tumor group represents 74 barcodes and the no-subsequent tumor group represents 224 barcodes. (B) Average number of oncoproteins mutated for Negative vs. Positive outcome (STAD p < 0.026, BLCA not significant) (detailed in SOM file labeled, “SOM Figures 1, 2 and 3, source file”). The negative outcome group represents 32 barcodes and the positive outcome group represents 71 barcodes.
Figure 2.
Figure 2.
(A) Oncoprotein mutation averages for New Tumor vs. No-subsequent tumor (STAD p < 0.007, BLCA not significant) (detailed in SOM file labeled, “SOM Figures 1, 2 and 3, source file”). The new tumor group represents 74 barcodes and the no-subsequent tumor group represents 224 barcodes. (B) Tumor suppressor mutation averages for New Tumor vs. No-subsequent tumor (STAD p < 0.019, BLCA not significant) (detailed in SOM file labeled, “SOM Figures 1, 2 and 3, source file”). The new tumor group represents 74 barcodes and the no-subsequent tumor group represents 224 barcodes. (C) Total mutation averages for New Tumor vs. No-subsequent tumor (STAD p< 0.004, BLCA not significant) (detailed in the SOM file labeled, “SOM Figures 1, 2 and 3, source file”). The new tumor group represents 74 barcodes and the no-subsequent tumor group represents 224 barcodes.
Figure 3.
Figure 3.
(A) Oncoprotein mutation averages for Negative and Positive outcome (STAD p < 0.042, BLCA not significant) (detailed in SOM file labeled, “SOM Figures 1, 2 and 3, source file”). The negative outcome group represents 32 barcodes and the positive outcome group represents 71 barcodes. (B) Tumor suppressor mutation averages for Negative and Positive outcome (Both STAD and BLCA are not significant) (detailed in SOM file labeled, “SOM Figures 1, 2 and 3, source file”). The negative outcome group represents 32 barcodes and the positive outcome group represents 71 barcodes. (C) Total mutation averages for Negative vs. Positive outcome (STAD and BLCA are not significant) (detailed in SOM file labeled, “SOM Figure 1, 2 and 3, source file”). The negative outcome group represents 32 barcodes and the positive outcome group represents 71 barcodes.

Similar articles

Cited by

References

    1. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WG Jr, Livingston DM, Orkin SH, Greenberg ME. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996; 85(4):549-61; PMID:8653790; http://dx.doi.org/10.1016/S0092-8674(00)81255-6 - DOI - PubMed
    1. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 1996; 85(4):537-48; PMID:8653789; http://dx.doi.org/10.1016/S0092-8674(00)81254-4 - DOI - PubMed
    1. Oswald F, Dobner T, Lipp M. The E2F transcription factor activates a replication-dependent human H2A gene in early S phase of the cell cycle. Mol Cell Biol 1996; 16(5):1889-95; PMID:8628255; http://dx.doi.org/10.1128/MCB.16.5.1889 - DOI - PMC - PubMed
    1. Banerjee D, Ercikan-Abali E, Waltham M, Schnieders B, Hochhauser D, Li WW, Fan J, Gorlick R, Goker E, Bertino JR. Molecular mechanisms of resistance to antifolates, a review. Acta Biochimica Polonica 1995; 42(4):457-64; PMID:8852336 - PubMed
    1. Kirch HC, Putzer B, Schwabe G, Gnauck HK, Schulte Holthausen H. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation. Cell Mol Biol Res 1993; 39(8):705-16; PMID:7951410 - PubMed